Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005793
Filing Date
2024-04-25
Accepted
2024-04-25 17:20:07
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 DEF 14A vygr-20240605xdef14a.htm DEF 14A 1033662
2 GRAPHIC vygr-20240605xdef14a_a004.jpg GRAPHIC 48577
3 GRAPHIC vygr-20240605xdef14a_a009.jpg GRAPHIC 59315
4 GRAPHIC vygr-20240605xdef14a_a010.jpg GRAPHIC 57637
5 GRAPHIC vygr-20240605xdef14a_bg001.jpg GRAPHIC 134021
6 GRAPHIC vygr-20240605xdef14a_bg002.jpg GRAPHIC 114564
  Complete submission text file 0001558370-24-005793.txt   1605767
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37625 | Film No.: 24877545
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)